Helixgate

Helixgate

Uncategorized

Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs

Published

on

With programs from Eisai and Hansoh Pharmaceutical in hand, Tortugas Neuroscience has emerged with hopes of delivering daily oral treatments to patients with central nervous system conditions.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Merck’s Welireg combo fails in first-line kidney cancer

Published

on

Adding Merck’s Welireg to an existing Keytruda regimen didn’t lead to a significant improvement in newly diagnosed patients with advanced kidney cancer, Merck announced on Tuesday.

The results mark a setback …

Continue Reading

Uncategorized

Merck’s fast-ascending kidney cancer drug hits a setback

Welireg’s failure in first-line kidney cancer removes a blockbuster opportunity and could leave an opening for a rival drug from Arcus Biosciences, analysts said.

Read More

Published

on

Welireg’s failure in first-line kidney cancer removes a blockbuster opportunity and could leave an opening for a rival drug from Arcus Biosciences, analysts said.

Read More

Continue Reading

Uncategorized

UnitedHealth breaks down how it plans to spend $1.5B on AI

UnitedHealth breaks down how it plans to spend $1.5B on AI

Published

on

UnitedHealth Group said Tuesday it’s on track to invest $1.5 billion in artificial intelligence this year, both to improve its own operations and provide products to other insurers and healthcare providers.

The healthcare giant is …​ ​Read More

Continue Reading
Advertisement

Trending